GlassScriptPhysician profile
Dejan Lukovic
NPI 1427545854
$873.98
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.61 · 2022: $270 · 2023: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508 · Education: $62.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.57 |
| Education | $62.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $198.45 | 2022-2023 | Evusheld, Lokelma, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $159.67 | 2022-2023 | |
| Alexion Pharmaceuticals, INC. | $150.43 | 2023 | Ultomiris |
| Nxstage Medical, INC. | $99.17 | 2022 | |
| Opko Pharmaceuticals, LLC | $62.08 | 2023 | Rayaldee |
| Otsuka America Pharmaceutical, INC. | $43.90 | 2021-2023 | Jynarque |
| Travere Therapeutics, INC. | $42.64 | 2023 | |
| Calliditas Therapeutics US INC. | $38.82 | 2023 | Tarpeyo |
| Horizon Therapeutics Plc | $23.08 | 2021 | |
| Aurinia Pharma U.S., INC. | $19.30 | 2023 | Lupkynis |
| Vifor Pharma, INC. | $18.42 | 2023 | Veltassa |
| Amgen INC. | $18.02 | 2023 | Tavneos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dejan Lukovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.